Interethnic and intraethnic variability of CYP2C8 and CYP2C9 polymorphisms in healthy individuals.

Molecular Diagnosis & Therapy
Elena García-MartínJosé A G Agúndez

Abstract

Cytochrome P450 (CYP) superfamily members CYP2C8 and CYP2C9 are polymorphically expressed enzymes that are involved in the metabolic inactivation of several drugs, including, among others, antiepileptics, NSAIDs, oral hypoglycemics, and anticoagulants. Many of these drugs have a narrow therapeutic index, and growing evidence indicates a prominent role of CYP2C8 and CYP2C9 polymorphisms in the therapeutic efficacy and in the development of adverse effects among patients treated with drugs that are CYP2C8 or CYP2C9 substrates. In this review, we summarize present knowledge on human variability in the frequency of variant CYP2C8 and CYP2C9 alleles. Besides an expected interethnic variability in allele frequencies, a large intraethnic variability exists. Among Asian subjects, for example, statistically significant differences (p < 0.0001) in CYP2C9*3 allele frequencies between Chinese and Japanese individuals have been reported. In addition, individuals from East Asia present different allele frequencies for CYP2C9*2 and CYP2C9*3 compared with South Asian subjects (p < 0.0001). Among Caucasian Europeans, statistically significant differences for the frequency of CYP2C8*3, CYP2C9*2, and CYP2C9*3 exist (p < 0.0001). This indicates th...Continue Reading

References

Dec 1, 1994·Pharmacogenetics·J A Goldstein, S M de Morais
Jun 1, 1996·Archives of Biochemistry and Biophysics·D C ZeldinS Wu
Aug 1, 1996·Pharmacogenetics·T H Sullivan-KloseJ A Goldstein
Oct 1, 1996·Pharmacogenetics·M J StubbinsC R Wolf
Jan 1, 1997·European Journal of Clinical Pharmacology·U Bissinger, V Nigrovic
Nov 14, 1997·Pharmacogenetics·K NasuT Ishizaki
Jun 19, 1998·Therapeutic Drug Monitoring·M KimuraS Higuchi
Jan 28, 1999·Biochemical and Biophysical Research Communications·U YasarF Sjöqvist
Sep 14, 1999·Biochemical Pharmacology·L Nadin, M Murray
Sep 16, 1999·Journal of Biochemical and Molecular Toxicology·T S KloseJ A Goldstein
Oct 6, 1999·Lancet·M S OggS E Humphries
Oct 6, 1999·British Journal of Clinical Pharmacology·A S AynaciogluI Roots
Apr 12, 2001·British Journal of Clinical Pharmacology·Y R YoonJ G Shin
May 25, 2001·European Journal of Clinical Pharmacology·E García-MartínJ A Agúndez
Oct 27, 2001·British Journal of Clinical Pharmacology·M G ScordoM Ingelman-Sundberg
Nov 8, 2001·Canadian Journal of Physiology and Pharmacology·A GaedigkJ S Leeder
Apr 3, 2002·JAMA : the Journal of the American Medical Association·Mitchell K HigashiAllan E Rettie
Aug 2, 2002·Carcinogenesis·Kari Hemminki, Asta Försti
Oct 31, 2002·Advanced Drug Delivery Reviews·Hong-Guang XieC Michael Stein
Nov 7, 2002·Carcinogenesis·Christoph SachseUNKNOWN Colorectal Cancer Study Group
Nov 19, 2002·Biochemical and Biophysical Research Communications·Umit YasarAnders Rane
Nov 27, 2002·European Journal of Clinical Pharmacology·Umit YasarAgneta Wennerholm
Jan 18, 2003·Pharmacology & Toxicology·Akiko SoyamaJun-ichi Sawada
May 8, 2003·European Journal of Clinical Pharmacology·Pedro DoradoAdrián LLerena
May 21, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Miki NakajimaTsuyoshi Yokoi
Jun 14, 2003·Fundamental & Clinical Pharmacology·Jue Quin YangLaurent Becquemont

❮ Previous
Next ❯

Citations

Apr 22, 2009·The Pharmacogenomics Journal·William C SpeedKenneth K Kidd
Feb 9, 2012·Genetic Testing and Molecular Biomarkers·Kristina PechandovaOndrej Slanar
Dec 4, 2009·BMC Medical Genetics·William KudziJeremy J Mills
Mar 28, 2008·BMC Medical Genetics·Elena García-MartínJosé Ag Agúndez
May 30, 2013·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Marek PostulaGrzegorz Opolski
Apr 5, 2011·Cleveland Clinic Journal of Medicine·Joseph P KitzmillerWolfgang Sadee
Aug 23, 2011·Ghana Medical Journal·Jairo A Garcia A, Lewis R Roberts
Feb 29, 2008·Pharmacogenomics·José A G Agúndez, José M Ladero
Jul 20, 2007·Pharmacogenomics·Helen Steed, Michael B Sawyer
Jan 5, 2013·Neurology India·Akanksha N ThakkarUrmila M Thatte
Jun 26, 2013·Wiener klinische Wochenschrift·Daniela KniepeissWilfried Renner
Apr 13, 2013·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Vincent Lai Ming Yip, Munir Pirmohamed
Aug 16, 2011·European Journal of Clinical Pharmacology·Chang-Ik ChoiSeok-Yong Lee
May 4, 2013·Expert Review of Molecular Diagnostics·Pilar H SaladoresMatthias Schwab
Sep 15, 2015·Expert Opinion on Pharmacotherapy·Pietro MerliFranco Locatelli
Apr 1, 2009·Expert Opinion on Drug Metabolism & Toxicology·Viet Hong PhanStephen J Clarke
Sep 29, 2011·Expert Opinion on Drug Metabolism & Toxicology·Viet Hong PhanStephen J Clarke
Apr 10, 2013·Expert Opinion on Drug Metabolism & Toxicology·José A G AgúndezFélix Javier Jiménez-Jiménez
Apr 18, 2013·Drug Metabolism Reviews·Marco AlessandriniMichael Sean Pepper
Aug 2, 2013·Expert Opinion on Drug Metabolism & Toxicology·Elena García-MartínJosé A G Agúndez
Nov 17, 2012·Expert Opinion on Drug Metabolism & Toxicology·Andreas HolsteinPeter Kovacs
Feb 1, 2012·Expert Opinion on Drug Metabolism & Toxicology·Joseph McGraw, Donald Waller
Apr 9, 2011·Expert Opinion on Drug Metabolism & Toxicology·José Ag AgúndezElena García-Martín
Jan 2, 2016·Pharmacological Reviews·Janne T BackmanPertti J Neuvonen
Jan 23, 2010·Pharmacology & Therapeutics·Beshay N M Zordoky, Ayman O S El-Kadi
Nov 21, 2009·The Lancet Infectious Diseases·Reinhold KerbMatthias Schwab
Nov 18, 2008·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Alberto M BorobiaAntonio J Carcas
Oct 8, 2011·Basic & Clinical Pharmacology & Toxicology·Daniela D VargensGuilherme Suarez-Kurtz
Jul 6, 2011·Basic & Clinical Pharmacology & Toxicology·Chang-Ik ChoiSeok-Yong Lee
Jul 29, 2015·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Elizabeth E RougheadNicole L Pratt
Nov 2, 2011·Drug Metabolism and Pharmacokinetics·Kazuma KiyotaniHitoshi Zembutsu
Jun 22, 2016·Drug Metabolism and Pharmacokinetics·Lay Kek TehMohd Zaki Salleh
Jun 20, 2016·European Journal of Medicinal Chemistry·Susan LepriGabriele Cruciani
May 28, 2016·Annals of Human Biology·Sara Flores-GutiérrezDinorah Castro de Guerra
Jul 6, 2016·Archives of Pharmacal Research·Hyun-Jee LeeChang-Ik Choi
Sep 13, 2016·Genetic Testing and Molecular Biomarkers·Ana Miriam Saldaña-CruzSilvia Esperanza Flores-Martínez
Oct 22, 2015·PloS One·Julia C StinglRuppert Gerzer
Mar 11, 2017·Genetic Testing and Molecular Biomarkers·Driss AfilalEl Hassan Izaabel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical and Experimental Pharmacology & Physiology
Negin ZandIraj Milanian
Current Opinion in Drug Discovery & Development
Zaynah K AliFrancis M Ysla
© 2022 Meta ULC. All rights reserved